{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:55:33Z","timestamp":1790751333382,"version":"4.1.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Yaobitong capsule is frequently co-administered with celecoxib for low back pain in China, but its incremental effectiveness and safety in routine clinical practice remain uncertain. We compared Yaobitong plus celecoxib with celecoxib alone and explored potential biological mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter retrospective cohort study included Chinese outpatients with low back pain treated at 3 hospitals. After 1:1 propensity score matching, 150 patients receiving Yaobitong plus celecoxib were compared with 150 receiving celecoxib alone. The primary outcome was the change in the Oswestry Disability Index (ODI) at 1 month. Secondary outcomes included pain, lumbar function, clinically meaningful response, rescue analgesic use, treatment escalation, and adverse events. Network pharmacology was conducted as an exploratory analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, measured baseline characteristics were balanced. At 1 month, the mean ODI reduction was 20.8 points with combination therapy and 14.6 points with celecoxib alone (between-group difference, \u22126.2 points; 95% CI, \u22128.36 to \u22124.04). Combination therapy was also associated with greater reductions in low back and leg pain and greater improvement in JOA score. Clinically meaningful ODI improvement occurred in 80.7% versus 64.0% of patients. Rescue analgesic use and treatment escalation were less frequent with combination therapy. Adverse events occurred in 19.3% and 16.0% of patients, respectively; no serious adverse events were documented. Exploratory network analyses highlighted cytokine- and inflammation-related targets and pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adding Yaobitong to celecoxib may be associated with greater short-term improvement in disability, pain, and lumbar function, with no clear between-group difference in adverse events. Randomized trials with longer follow-up are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpain.2026.1915365","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:01:02Z","timestamp":1790748062000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Yaobitong plus celecoxib for low back pain: a Chinese multicenter cohort and network pharmacology study"],"prefix":"10.3389","volume":"7","author":[{"given":"Huahui","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanghao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyou","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Taizhou Hospital of Traditional Chinese Medicine","place":["Taizhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2665-9913(23)00232-1","article-title":"Global, regional, and national burden of other musculoskeletal disorders, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"5","author":"Gill","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0140-6736(21)00733-9","article-title":"Low back pain","volume":"398","author":"Knezevic","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e31533","DOI":"10.1097\/MD.0000000000031533","article-title":"Efficacy and safety of yaobitong capsule for acute lumbar disc herniation: a protocol for a multi-center randomized controlled trial","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jama.2026.9631","article-title":"Low back pain: a review","volume":"336","author":"Cashin","year":"2026","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.7326\/ANNALS-25-04645","article-title":"Effectiveness of nonpharmacologic treatments for chronic low back pain: a sequential, multiple-assignment, randomized trial","volume":"179","author":"Fritz","year":"2026","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/S0140-6736(18)30489-6","article-title":"Prevention and treatment of low back pain: evidence, challenges, and promising directions","volume":"391","author":"Foster","year":"2018","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/bjsports-2020-102723","article-title":"Treating low back pain in athletes: a systematic review with meta-analysis","volume":"55","author":"Thornton","year":"2021","journal-title":"Br J Sports Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"CD012087","DOI":"10.1002\/14651858.CD012087","article-title":"Non-steroidal anti-inflammatory drugs for chronic low back pain","volume":"2","author":"Enthoven","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40265-025-02234-5","article-title":"Current evidence on celecoxib safety in the management of chronic musculoskeletal conditions","volume":"85","author":"Beaudart","year":"2025","journal-title":"An Umbrella Review. Drugs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1056\/NEJMcp1512658","article-title":"Herniated lumbar intervertebral disk","volume":"374","author":"Deyo","year":"2016","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e070730","DOI":"10.1136\/bmj-2022-070730","article-title":"Surgical versus non-surgical treatment for sciatica: systematic review and meta-analysis of randomised controlled trials","volume":"381","author":"Liu","year":"2023","journal-title":"Br Med J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(23)00404-X","article-title":"Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial","volume":"402","author":"Jones","year":"2023","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jebm.12598","article-title":"An evidence-based guideline on treating lumbar disc herniation with traditional Chinese medicine","volume":"17","author":"Qin","year":"2024","journal-title":"J Evid Based Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17219\/acem\/185523","article-title":"Safety and efficacy of yaobitong capsules for lumbar disc herniation: a multicenter, randomized, double-blinded, parallel, positive-controlled clinical trial","volume":"34","author":"Zhao","year":"2025","journal-title":"Adv Clin Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1039\/D1AY01564H","article-title":"The systematic characterization of multiple components and metabolic profiling of bioactive constituents in yaobitong capsule by UHPLC\/Q-TOF-MS\/MS","volume":"13","author":"Bai","year":"2021","journal-title":"Anal Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"113097","DOI":"10.1016\/j.jep.2020.113097","article-title":"Systematically characterized mechanism of treatment for lumbar disc herniation based on yaobitong capsule ingredient analysis in rat plasma and its network pharmacology strategy by UPLC-MS\/MS","volume":"260","author":"Deng","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.apjtm.2015.09.014","article-title":"Effect of yaobitong capsule on histomorphology of dorsal root ganglion and on expression of p38mark phosphorylation in autologous nucleus pulposus transplantation model of rats","volume":"8","author":"Xin","year":"2015","journal-title":"Asian Pac J Trop Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"107197","DOI":"10.1016\/j.fitote.2026.107197","article-title":"Identifying the effective components of yaobitong capsule against lumbar disc herniation using a multi-technique strategy","volume":"190","author":"Liu","year":"2026","journal-title":"Fitoterapia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13643-025-02963-4","article-title":"Efficacy and safety of Chinese herbal compounds for lumbar disc herniation: a systematic review of randomized controlled trials","volume":"14","author":"Guan","year":"2025","journal-title":"Syst Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1700862","DOI":"10.3389\/fneur.2025.1700862","article-title":"Efficacy of oblique pulling manipulation combined with adjunct therapies (massage\/acupuncture\/herbal medicine\/injection) for lumbar disc herniation: a systematic review and meta-analysis of pain and functional outcome","volume":"16","author":"Li","year":"2025","journal-title":"Front Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000540324","article-title":"Cytokines in cerebrospinal fluid and chronic pain in humans: past, present, and future","volume":"31","author":"Rosenstrom","year":"2024","journal-title":"Neuroimmunomodulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1636860","DOI":"10.3389\/fmed.2025.1636860","article-title":"Identification of novel gut microbiota-related biomarkers in cerebral hemorrhagic stroke","volume":"12","author":"Ye","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jgr.2025.03.008","article-title":"Ginsenoside Rh2 alleviates inflammatory response and enhances motor function recovery in spinal cord injury mice via the ROS\/MAPK14 signaling pathway","volume":"49","author":"Wu","year":"2025","journal-title":"J Ginseng Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1404738","DOI":"10.3389\/fphar.2024.1404738","article-title":"Exploration of the mechanism of traditional Chinese medicine for anxiety and depression in patients with diarrheal irritable bowel syndrome based on network pharmacology and meta-analysis","volume":"15","author":"Bai","year":"2024","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"155258","DOI":"10.1016\/j.phymed.2023.155258","article-title":"Inhibition of inflammation by berberine: molecular mechanism and network pharmacology analysis","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1915365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:01:03Z","timestamp":1790748063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1915365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":25,"alternative-id":["10.3389\/fpain.2026.1915365"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2026.1915365","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1915365"}}